Can You Get Mounjaro on the NHS in 2025? UK Access Explained
Complete guide to NHS Mounjaro access in the UK: current eligibility criteria, how to request a prescription, regional variations, costs, waiting times, and what to do if your NHS application is denied.
🎯 Key Takeaways
- Yes, Mounjaro is available on the NHS – but only for Type 2 diabetes patients who meet strict eligibility criteria
- Not available for weight loss alone – you must have confirmed Type 2 diabetes to qualify for NHS prescription in 2025
- Cost: £9.90 per month in England (standard NHS prescription charge) vs £200-£350+ private – a savings of over 95%
- Regional "postcode lottery" exists – availability varies dramatically across the UK's 42 Integrated Care Boards (ICBs)
- Strict eligibility: BMI ≥30 kg/m², HbA1c above target, previous trial of metformin + other diabetes medications required
- Waiting times vary: 1-2 weeks via GP direct prescribing, or 8-16 weeks via specialist referral pathway
- Many GPs reluctant to prescribe due to budget constraints – even if you meet clinical criteria, access isn't guaranteed
If you're hoping to access Mounjaro (tirzepatide) through the NHS in the UK, you need to understand the complex landscape of eligibility, regional variations, and prescribing pathways. The short answer: yes, NHS Mounjaro is available – but only for specific patients, and access varies dramatically depending on where you live.
This comprehensive guide explains everything UK patients need to know about NHS Mounjaro access in 2025: current licensing status, who qualifies, how to request a prescription, costs, waiting times, and what to do if NHS access is denied.
⚕️ Quick Answer: NHS Mounjaro Status (October 2025)
Mounjaro is licensed and available on the NHS for Type 2 diabetes management in patients who meet specific criteria. It is NOT routinely available for weight loss alone (obesity without diabetes) on the NHS as of October 2025.
Key facts:
- MHRA-approved for Type 2 diabetes (all doses 2.5mg-15mg)
- NICE recommends tirzepatide for diabetes in specific circumstances
- Each ICB (Integrated Care Board) decides local funding and access
- Prescription charge: £9.90 in England; free in Scotland, Wales, N. Ireland
- Availability subject to local budget constraints and supply
NHS Mounjaro Eligibility Criteria 2025
To qualify for NHS-funded Mounjaro, you must meet ALL of the following criteria (based on NICE guidance and typical ICB policies):
✓ NHS Mounjaro Eligibility Checklist
- Confirmed Type 2 diabetes diagnosis – documented in medical records with HbA1c or fasting glucose tests
- BMI ≥30 kg/m² (or ≥27.5 kg/m² if you're from South Asian, Chinese, other Asian, Middle Eastern, Black African, or African-Caribbean background)
- HbA1c above individualized target despite current treatment (typically HbA1c >58 mmol/mol / 7.5%)
- Already tried metformin and at least one other diabetes medication (e.g., SGLT2 inhibitors, sulfonylureas, DPP-4 inhibitors)
- No contraindications – no history of medullary thyroid carcinoma, MEN 2 syndrome, severe gastroparesis, or pregnancy/breastfeeding
- Willing to attend monitoring appointments – quarterly reviews to assess HbA1c, weight, and side effects
- Living in an area where your ICB funds Mounjaro – this varies significantly across England
- Evidence of commitment to lifestyle changes – diet and exercise modifications alongside medication
Who Does NOT Qualify for NHS Mounjaro?
The following patients are NOT eligible for NHS Mounjaro as of October 2025:
- People wanting Mounjaro for weight loss only (obesity without Type 2 diabetes)
- Type 1 diabetes patients – Mounjaro is not licensed for Type 1 diabetes
- People with BMI <30 kg/m² (or <27.5 kg/m² for relevant ethnic groups), even with diabetes
- Those who haven't tried other diabetes medications first – Mounjaro is not a first-line treatment on NHS
- Patients with contraindications (thyroid cancer history, MEN 2, pregnancy)
- People in areas where ICB doesn't fund Mounjaro – even if clinically eligible
⚠️ Important: Obesity-Only Prescribing
NICE has recommended tirzepatide (Mounjaro) for weight management in adults with obesity, BUT this has not translated into widespread NHS availability as of October 2025.
Why the delay? High cost (£200+ per patient per month), supply constraints, and budget pressures have prevented most ICBs from funding Mounjaro for obesity-only indications. Some pilot NHS weight management programs include Mounjaro, but these have extremely limited capacity and long waiting lists (12-18 months in some areas).
Bottom line: If you want Mounjaro for weight loss only (without Type 2 diabetes), you'll almost certainly need to access it privately in 2025.
How to Get an NHS Mounjaro Prescription (Step-by-Step)
If you meet the eligibility criteria above, here's the process to request NHS Mounjaro:
Request a review of your Type 2 diabetes management. Mention that your HbA1c remains above target despite current medications, and you'd like to discuss treatment escalation options including Mounjaro.
Tip: Book a double appointment (20 minutes) to allow adequate discussion time.
Your GP will review your medical history, current medications, recent HbA1c results, BMI, and assess you against NICE guidelines and local ICB criteria.
Bring: Recent blood test results, list of all current medications and doses, weight/BMI records.
Option A: GP Direct Prescribing – Some GPs can prescribe Mounjaro directly if you meet all criteria and their ICB permits it. Prescription issued within 1-2 weeks.
Option B: Specialist Referral – Many ICBs require endocrinologist approval before prescribing. GP refers you to diabetes clinic. Appointment in 8-16 weeks typically.
Option C: Denial – GP explains why you don't meet criteria, or states that local ICB doesn't fund Mounjaro. (See section below on what to do if denied.)
Endocrinologist or diabetes specialist nurse assesses your case, confirms eligibility, and approves prescription. May require additional tests (HbA1c, kidney function, liver function).
You'll receive a prescription for Mounjaro 2.5mg (starting dose). Collect from NHS pharmacy, paying £9.90 prescription charge (England) or free (Scotland/Wales/N. Ireland).
Starting dose: All patients start on 2.5mg regardless of weight, then escalate every 4 weeks.
Monthly prescriptions: You'll need a new prescription every month as dose increases (2.5mg → 5mg → 7.5mg → etc.).
Quarterly reviews: GP or diabetes clinic will review your HbA1c, weight loss, side effects, and continuation criteria every 3 months.
Discontinuation criteria: NHS may stop funding if HbA1c doesn't improve by ≥5 mmol/mol (0.5%) within 6 months, or if you don't lose ≥3% body weight.
Prescription Renewal Process
Once you're established on NHS Mounjaro:
- Repeat prescriptions: Request via NHS App, online services, or in person (same as any repeat prescription)
- Collection: Your usual NHS pharmacy; ensure they have Mounjaro in stock (call ahead to check)
- Dose escalation: GP or specialist will update your prescription dose every 4 weeks during titration phase
- Monitoring bloods: HbA1c every 3 months, kidney and liver function every 6 months typically
NHS Mounjaro Costs vs Private Costs
One of the biggest advantages of NHS access is the dramatic cost savings compared to private prescriptions:
NHS Cost (England)
Per 4-dose pen (4 weeks of treatment)
Standard NHS prescription charge. Covers starting dose (2.5mg) through maximum dose (15mg).
Annual cost: £118.80 (12 prescriptions)
Or get Prescription Prepayment Certificate: £114.50/year for unlimited prescriptions
NHS Cost (Scotland/Wales/NI)
Per 4-dose pen (4 weeks of treatment)
Prescriptions are free in Scotland, Wales, and Northern Ireland for all patients.
Annual cost: £0
Completely free at point of use if you meet NHS eligibility criteria
Private Cost (UK Average)
Per 4-dose pen (4 weeks of treatment)
Varies by dose (2.5mg cheapest, 15mg most expensive) and pharmacy. Includes private consultation fees.
Annual cost: £2,400-£4,200
Full private pathway – guaranteed access but expensive
💰 Potential Savings: Over £4,000 per Year
If you qualify for NHS Mounjaro in England, you'll save approximately £2,280-£4,080 per year compared to private prescriptions (even after paying £118.80 in prescription charges).
In Scotland, Wales, and Northern Ireland, where prescriptions are free, you'll save the full £2,400-£4,200 per year – an enormous financial benefit for eligible patients.
NHS Prescription Prepayment Certificate (PPC)
If you're in England and will need Mounjaro long-term, a Prescription Prepayment Certificate can save money:
- 3-month PPC: £32.05 (covers unlimited prescriptions for 3 months)
- 12-month PPC: £114.50 (covers unlimited prescriptions for 1 year)
- Break-even: If you need ≥4 items in 3 months or ≥12 items in a year, PPC saves money
- Mounjaro alone: 12 prescriptions/year = £118.80 without PPC, £114.50 with annual PPC (saves £4.30)
- If you have other prescriptions too: PPC becomes very cost-effective (diabetes meds, blood pressure meds, etc.)
How to get PPC: Apply online at nhsbsa.nhs.uk/help-nhs-prescription-costs or ask at any pharmacy.
The NHS "Postcode Lottery": Regional Variations
One of the most frustrating aspects of NHS Mounjaro access is the postcode lottery – significant regional variations in availability and prescribing policies.
Why Does Availability Vary?
England's NHS is divided into 42 Integrated Care Boards (ICBs), each with independent budgets and prescribing policies. Scotland, Wales, and Northern Ireland have separate health systems. This creates inconsistency:
- Some ICBs actively fund Mounjaro for all eligible diabetes patients
- Other ICBs restrict funding to only the most severe cases (very high HbA1c, multiple complications)
- Some ICBs have waiting lists due to budget caps (e.g., only 50 patients funded per quarter)
- Supply shortages affect some regions more than others
⚠️ Real Example: The Postcode Lottery in Action
Patient A (London, certain ICB): Type 2 diabetes, BMI 32, HbA1c 65 mmol/mol, tried metformin + gliclazide. Result: NHS Mounjaro approved within 2 weeks via GP.
Patient B (Different region, different ICB): Identical clinical profile. Result: NHS Mounjaro denied. ICB policy requires HbA1c >75 mmol/mol AND BMI >35 AND evidence of cardiovascular disease. Patient forced to use private prescription (£300/month).
This is the reality of NHS regional variation. Your eligibility depends as much on geography as clinical need.
How to Check Your Local ICB Policy
- Find your ICB: Visit nhs.uk and enter your postcode to identify your local ICB
- Check local formulary: Search "[Your ICB name] medicines formulary tirzepatide" or "Mounjaro"
- Ask your GP: They have access to local prescribing policies and can explain specific criteria
- Contact ICB directly: Call or email your ICB's medicines management team for clarification
Scotland, Wales, and Northern Ireland
- Scotland: NHS Scotland follows separate SIGN (Scottish Intercollegiate Guidelines Network) guidance. Mounjaro available for eligible Type 2 diabetes patients. Free prescriptions.
- Wales: NHS Wales has its own All Wales Medicines Strategy Group (AWMSG). Mounjaro approved for Type 2 diabetes. Free prescriptions.
- Northern Ireland: Separate HSC (Health and Social Care) system. Mounjaro available but may have longer specialist waiting times. Free prescriptions.
NHS Mounjaro Waiting Times (2025)
How long does it take to get NHS Mounjaro once you decide to pursue it? Here's the typical timeline:
| Pathway | Timeline | Notes |
|---|---|---|
| GP Direct Prescribing | 1-2 weeks | If GP can prescribe without specialist approval. Fastest route. Not available in all ICB areas. |
| GP Referral to Diabetes Clinic | 8-16 weeks | Routine referral to NHS endocrinology. Appointment + assessment + prescription approval. |
| Tier 3 Weight Management Service | 6-18 months | Specialist NHS weight management programs. Very long waiting lists. Limited capacity. |
| Supply Delays | +2-6 weeks | Occasional shortages can delay NHS prescriptions even after approval. Check pharmacy stock. |
| Private Prescription (comparison) | 24-48 hours | Online consultation → prescription → delivery. Fastest access but expensive. |
How to Minimize Waiting Times
- Choose a proactive GP practice: Some practices are more willing to prescribe newer diabetes medications
- Have all documentation ready: Recent HbA1c, weight records, medication history speeds up assessment
- Request urgent referral if appropriate: If you have severe uncontrolled diabetes or complications, ask for urgent specialist review
- Check pharmacy stock in advance: Call your NHS pharmacy before collecting prescription to ensure Mounjaro is in stock
- Consider bridging with private prescription: Start private Mounjaro while waiting for NHS approval, then switch once approved
What to Do If NHS Denies Your Mounjaro Request
If your GP or ICB denies NHS Mounjaro access, you have several options:
1. Understand the Reason for Denial
Ask your GP to clearly explain why you don't qualify:
- Clinical criteria not met? (e.g., BMI too low, HbA1c not high enough, haven't tried enough other medications)
- Local ICB policy restriction? (you meet NICE criteria but ICB has stricter rules)
- Budget constraints? (ICB has funding cap or waiting list)
- Supply issues? (temporary shortage)
2. Request a Second Opinion / Specialist Referral
If you believe you meet criteria but GP disagrees:
- Ask for referral to NHS endocrinologist for specialist diabetes assessment
- Request second opinion from different GP in your practice (GPs have varying prescribing approaches)
- Contact diabetes specialist nurse (many GP practices have DSNs who can advocate)
3. Check if Clinical Criteria Can Be Met
If you're close but not quite eligible:
- Optimize current medications: Demonstrate you've genuinely tried metformin + other drugs at maximum tolerated doses
- Repeat HbA1c test: If borderline, retest in 3 months (may be higher, demonstrating need)
- Document weight and BMI: Ensure accurate measurement (some patients underestimate)
4. Make a Formal Complaint (If Appropriate)
If you believe the denial is unjustified:
- NHS complaints procedure: Complain to GP practice manager, then ICB if unsatisfied
- Individual Funding Request (IFR): In exceptional circumstances, request special funding consideration from ICB
- Patient Advice and Liaison Service (PALS): Contact your local hospital PALS for advocacy support
5. Access Mounjaro Privately
If NHS access is denied or delayed, private prescription is the most reliable alternative:
✅ Private Mounjaro Access as Backup Option
If NHS access is denied or waiting times are too long, private prescription guarantees access (if clinically appropriate).
Private pathway:
- Online consultation with private prescriber (24-48 hours)
- Prescription issued if suitable (most patients with BMI ≥30 or ≥27 with weight-related conditions)
- Mounjaro delivered to your door
- Monthly cost: £200-£350+ depending on dose
- No waiting lists, guaranteed supply (stock permitting)
Cost comparison tool: Use our live price comparison to find the cheapest UK private pharmacies if NHS access isn't possible.
Future NHS Expansion: Will Mounjaro Become More Available?
Many UK patients ask: "Will NHS Mounjaro access expand in the future?" Here's what we know:
NICE Recommendations vs Real-World Implementation
NICE has recommended tirzepatide (Mounjaro) for weight management in adults with obesity, but implementation has been slow due to:
- Cost: £200-300+ per patient per month – expensive for NHS budgets already under pressure
- Demand: Millions of UK adults have obesity – universal access would cost billions annually
- Supply constraints: Global Mounjaro shortages have limited available stock
- Prioritization: NHS prioritizes Type 2 diabetes (life-threatening complication risk) over obesity alone
Predicted Timeline for Wider Access
📅 Our 2025-2027 Predictions
2025: NHS Mounjaro remains primarily for Type 2 diabetes. Limited obesity-only pilot programs continue but don't expand significantly. Regional variation persists.
2026: Possible gradual expansion if (1) Eli Lilly increases UK supply, (2) prices decrease through negotiations, (3) generic tirzepatide becomes available. Some ICBs may begin funding obesity-only use for patients with BMI ≥40 or BMI ≥35 with complications.
2027 onwards: Wider NHS access for weight management becomes more likely if clinical evidence continues to show long-term benefits (reduced diabetes incidence, cardiovascular events, healthcare cost savings). May require government policy priority shift.
Bottom line: Don't expect universal NHS Mounjaro access for weight loss alone in 2025. If you want it for obesity without diabetes, budget for private prescriptions for the foreseeable future.
Factors That Could Accelerate NHS Expansion
- Price reductions: If Eli Lilly negotiates lower NHS pricing (unlikely short-term)
- Generic competition: When tirzepatide patent expires (not until 2030s)
- Political priority: If government makes obesity treatment a strategic NHS priority
- Evidence of cost-effectiveness: Long-term studies showing healthcare cost savings outweigh medication costs
- Increased supply: When manufacturing capacity meets global demand
Frequently Asked Questions: NHS Mounjaro Access
Can you get Mounjaro on the NHS in 2025?
Yes, Mounjaro is available on the NHS for Type 2 diabetes patients who meet strict eligibility criteria. As of October 2025, NHS prescribing is primarily for diabetes management, not weight loss alone. You must have Type 2 diabetes, BMI ≥30 kg/m² (or ≥27.5 kg/m² for South Asian/Black African/Caribbean patients), have tried other diabetes medications first (metformin + at least one other), and have HbA1c above target. Availability varies significantly by region due to Integrated Care Board (ICB) budget constraints. If you want Mounjaro for weight loss only (without diabetes), you'll almost certainly need a private prescription in 2025.
What are the NHS eligibility criteria for Mounjaro?
NHS Mounjaro eligibility requires ALL of the following: (1) Confirmed Type 2 diabetes diagnosis with documented HbA1c/glucose tests. (2) BMI ≥30 kg/m² (or ≥27.5 kg/m² for certain ethnic groups: South Asian, Chinese, other Asian, Middle Eastern, Black African, African-Caribbean). (3) HbA1c above individualized target despite current treatment (typically >58 mmol/mol / 7.5%). (4) Previous trial of metformin and at least one other diabetes medication (SGLT2 inhibitor, sulfonylurea, DPP-4 inhibitor, etc.). (5) No contraindications (no history of medullary thyroid cancer, MEN 2 syndrome, severe gastroparesis, pregnancy/breastfeeding). (6) Willingness to attend quarterly monitoring appointments. (7) Living in an ICB area that funds Mounjaro. Not currently available on NHS for obesity without diabetes.
How much does Mounjaro cost on the NHS?
If you qualify for NHS Mounjaro, you pay the standard NHS prescription charge: £9.90 per item in England (covering a 4-dose pen / 4 weeks of treatment). Prescriptions are free in Scotland, Wales, and Northern Ireland. This makes NHS Mounjaro dramatically cheaper than private prescriptions which cost £200-£350+ per 4-dose pen depending on dose and pharmacy. If you need multiple prescriptions annually, a Prescription Prepayment Certificate (PPC) can save money: £32.05 for 3 months or £114.50 for 12 months, covering unlimited prescriptions. Annual cost: £118.80 without PPC, £114.50 with annual PPC (England); £0 (free) in Scotland/Wales/NI. Potential savings vs private: £2,280-£4,200+ per year.
How do I get a Mounjaro prescription on the NHS?
To request NHS Mounjaro: (1) Book a GP appointment to discuss your Type 2 diabetes management and mention that your HbA1c remains above target despite current medications. (2) GP assesses eligibility against NICE guidelines and local ICB criteria. (3) If eligible, GP may prescribe directly (1-2 weeks) or refer to specialist diabetes clinic (8-16 weeks for appointment). (4) Some areas require endocrinologist approval before prescribing. (5) Once approved, you'll receive monthly prescriptions (renewable), starting at 2.5mg and escalating every 4 weeks. (6) Expect quarterly monitoring appointments to check HbA1c, weight, and side effects. Bring recent blood results, medication list, and weight/BMI records to your appointment. Note: Many GPs are reluctant to prescribe due to budget constraints, even if you meet clinical criteria.
Why is Mounjaro availability different across the UK?
NHS Mounjaro availability varies due to the "postcode lottery" – each of the 42 Integrated Care Boards (ICBs) in England has its own budget and prescribing policies. Some ICBs prioritize funding Mounjaro for diabetes patients, while others restrict it due to high costs (£200+ per patient per month). Scotland, Wales, and Northern Ireland have separate health systems with different approval processes. This means identical patients in different regions may receive different answers from their NHS services. Urban areas with larger diabetes populations often have more restricted access than rural areas. Some ICBs have waiting lists or require higher HbA1c thresholds than NICE recommends. Your eligibility depends as much on geography as clinical need. To check your local policy, find your ICB on nhs.uk and search for their medicines formulary, or ask your GP about local prescribing criteria.
Can I get Mounjaro on the NHS for weight loss only?
No, as of October 2025, Mounjaro is NOT routinely available on the NHS for weight loss alone (obesity without Type 2 diabetes). NICE has recommended tirzepatide for weight management in specific circumstances, but widespread NHS rollout has been delayed due to cost (£200+ per patient per month), supply constraints, and budget pressures affecting all ICBs. You must have Type 2 diabetes to qualify for NHS Mounjaro currently. Some pilot NHS weight management programs may include Mounjaro, but availability is extremely limited (6-18 month waiting lists, capacity for only hundreds of patients nationally vs millions with obesity). If you want Mounjaro for weight loss only, you'll need to access it through private prescription services (£200-£350+ per month). Use our price comparison tool to find the cheapest verified UK private pharmacies.
What should I do if my NHS GP refuses to prescribe Mounjaro?
If your GP refuses NHS Mounjaro despite you meeting eligibility criteria: (1) Ask for a clear explanation of why you don't qualify – is it clinical criteria, ICB policy, or budget constraints? (2) Request referral to NHS endocrinologist or diabetes specialist for a second opinion and specialist assessment. (3) Check your local ICB's prescribing policy – ask GP to show you the local formulary criteria for Mounjaro. (4) Consider switching to a different GP practice in your area (different practices have varying prescribing attitudes and relationships with specialists). (5) Make a formal complaint through NHS complaints procedure if you believe the refusal is unjustified based on NICE guidelines. (6) Explore private prescription services as an alternative – costs £200-£350+ per month but guarantees access if clinically appropriate (BMI ≥30 or ≥27 with weight-related conditions). Most UK patients denied NHS access successfully obtain Mounjaro privately within 48 hours of online consultation.
How long are NHS Mounjaro waiting times?
NHS Mounjaro waiting times vary dramatically by region and pathway: (1) GP direct prescribing: 1-2 weeks if your GP can prescribe without specialist approval and agrees immediately. (2) Specialist referral pathway: 8-16 weeks for endocrinology appointment, then additional 2-4 weeks for prescription approval and issuing. (3) Tier 3 weight management services: 6-18 months waiting list in many areas due to limited capacity. (4) Supply issues: Occasional stock shortages can delay NHS prescriptions by 2-6 weeks even after approval – call pharmacy ahead to check availability. In contrast, private services typically prescribe within 24-48 hours of online consultation with delivery 2-5 days later. If you need to start treatment urgently for diabetes management, private access is significantly faster, though more expensive. Some patients start privately while waiting for NHS approval, then switch once NHS prescription is granted to benefit from lower costs long-term.
Summary: Your NHS Mounjaro Options in 2025
Here's the bottom line for UK patients considering NHS Mounjaro access:
✅ If You Have Type 2 Diabetes + Meet Eligibility Criteria:
NHS Mounjaro is worth pursuing. The cost savings are enormous (£9.90 vs £200-£350 per month), and many patients successfully obtain NHS prescriptions. Start with a GP appointment, bring documentation of your diabetes management history, and be prepared to advocate for yourself if needed. If your GP denies access, request specialist referral for second opinion.
Be realistic about waiting times: Direct GP prescribing takes 1-2 weeks; specialist referral takes 8-16 weeks. If you need faster access, consider starting privately while NHS approval is pending, then switching once approved.
⚠️ If You Want Mounjaro for Weight Loss Only (No Diabetes):
NHS access is extremely unlikely in 2025. Despite NICE recommendations for weight management use, ICB budget constraints mean obesity-only prescribing is virtually non-existent outside of limited pilot programs with 12-18 month waiting lists.
Private prescription is your realistic option. Costs £200-£350+ per month (dose-dependent), but guarantees access within 24-48 hours of consultation if clinically appropriate. Use our price comparison tool to find the cheapest verified UK pharmacies and save hundreds annually.
Final Recommendations
- Check your eligibility carefully before approaching GP – bring evidence you meet all criteria
- Understand your local ICB policy – research in advance to know if your area funds Mounjaro
- Be persistent but realistic – if NHS access is denied for legitimate reasons (budget/policy), don't delay treatment waiting for policy changes that may never come
- Consider private as backup plan – if NHS denies access or waiting times are prohibitive, private guarantees treatment
- Stay informed about policy changes – NHS Mounjaro access may expand in 2026-2027 if costs decrease or supply increases
Helpful Resources
- Live Mounjaro Price Comparison – Compare private UK pharmacy prices if NHS access denied
- Mounjaro UK Prices Guide 2025 – Complete private pricing breakdown by dose
- Complete Dose Guide – All 6 Mounjaro doses explained
- Mounjaro Side Effects Guide – What to expect and how to manage symptoms
- Mounjaro FAQ – 54 commonly asked questions answered
- NICE Guidance – Official NHS clinical guidelines for tirzepatide
- Diabetes UK – Patient advocacy and support for diabetes management
⚕️ Medical & Policy Disclaimer
This article provides educational information about NHS Mounjaro access policies as of October 2025. NHS policies, ICB funding decisions, and prescribing criteria change frequently. Always consult your GP or diabetes specialist for the most current information about NHS access in your specific area.
This is not medical advice. Decisions about diabetes treatment should be made in consultation with qualified healthcare professionals based on your individual circumstances, medical history, and local NHS availability.
Information about costs, waiting times, and regional availability is based on research and patient reports but may not reflect your specific ICB's current policy. Contact your GP practice or local ICB for definitive information.
Last updated: 11 October 2025 | Policy review: Based on NICE TA924, NHS England policies, and ICB formulary data | Accuracy note: NHS policies change frequently – verify current eligibility with your GP